Skip to main content

Table 1 Comparison of sham and dyslipidemia groups

From: Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia

 

Sham group (n = 5)

Dyslipidemia group (n = 5)

P value

Baseline

   

TG (mmol/L)

1.03 ± 0.16

1.05 ± 0.11

0.208

TC (mmol/L)

3.08 ± 0.25

3.02 ± 0.19

0.356

LDL-C (mmol/L)

1.89 ± 0.24

1.86 ± 0.18

0.188

HDL-C (mmol/L)

0.77 ± 0.10

0.75 ± 0.09

0.275

FBG (mmol/L)

4.23 ± 0.34

4.42 ± 0.39

0.106

NO (umol/L)

10.17 ± 1.08

10.20 ± 1.15

0.403

MDA (nmol/mL)

0.92 ± 0.04

0.90 ± 0.07

0.335

CRP (mg/L)

1.87 ± 0.15

1.91 ± 0.20

0.281

ADMA (nmol/L)

46.69 ± 4.32

47.18 ± 5.25

0.308

6 weeks later

  

TG (mmol/L)

1.10 ± 0.22

1.87 ± 0.34

0.016

TC (mmol/L)

3.24 ± 0.43

4.98 ± 0.77

0.003

LDL-C (mmol/L)

1.97 ± 0.46

3.00 ± 0.52

< 0.001

HDL-C (mmol/L)

0.82 ± 0.13

0.90 ± 0.10

0.078

FBG (mmol/L)

4.48 ± 0.49

4.50 ± 0.62

0.102

NO (umol/L)

10.46 ± 1.14

6.64 ± 1.08

< 0.001

MDA (nmol/L)

0.98 ± 0.06

3.78 ± 0.62

< 0.001

CRP (mg/L)

1.94 ± 0.23

4.22 ± 0.86

< 0.001

ADMA (nmol/L)

48.51 ± 4.74

66.32 ± 8.90

< 0.001